Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Antimicrobial"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Microbiota
Evaluation of commercial probiotic lactic cultures against biofilm formation by Cronobacter sakazakii
Anubhav Jamwal, Kavita Sharma, Rajni Chauhan, Saurabh Bansal, Gunjan Goel
Intest Res 2019;17(2):192-201.   Published online December 3, 2018
DOI: https://doi.org/10.5217/ir.2018.00106
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Cronobacter sakazakii, an emergent pathogen is considered as a major concern to infants and neonates fed on reconstituted powdered infant milk formula. In conjunction with many other factors, biofilm forming capacity adds to its pathogenic potential. In view of the facts that infants are at highest risk to C. sakazakii infections, and emerging antibiotic resistance among pathogens, it is imperative to evaluate probiotic cultures for their efficacy against C. sakazakii. Therefore, pure probiotic strains were isolated from commercial probiotic products and tested for their antimicrobial and anti-biofilm activities against C. sakazakii.
Methods
A total of 6 probiotic strains were tested for their antibiotic susceptibility followed by antimicrobial activity using cell-free supernatant (CFS) against C. sakazakii. The inhibitory activity of CFS against biofilm formation by C. sakazakii was determined using standard crystal violet assay and microscopic observations.
Results
All the probiotic strains were sensitive to ampicillin, tetracycline, vancomycin and carbenicillin whereas most of the strains were resistant to erythromycin and novobiocin. Four of the 6 probiotic derived CFS possessed antimicrobial activity against C. sakazakii at a level of 40 μL. A higher biofilm inhibitory activity (>80%) was observed at initial stages of biofilm formation with weaker activity during longer incubation upto 48 hours (50%–60%).
Conclusions
The study indicated the efficacy of isolated commercial probiotics strains as potential inhibitor of biofilm formation by C. sakazakii and could be further explored for novel bioactive molecules to limit the emerging infections of C. sakazakii.

Citations

Citations to this article as recorded by  
  • 2′-Fucosyllactose as a prebiotic modulates the probiotic responses of Bifidobacterium bifidum
    Jingfang Du, Hong Yang
    Current Research in Food Science.2025; 10: 100975.     CrossRef
  • Macro/Microgel‐Encapsulated, Biofilm‐Armored Living Probiotic Platform for Regenerating Bacteria‐Infected Diabetic Wounds
    Huilong Xin, Zhe Cai, Jiahui Hao, Jing An, Yi Li, Min Wen, Zhaojun Jia
    Advanced Healthcare Materials.2025;[Epub]     CrossRef
  • Exploring the potential of Weissella paramesenteroides UFTM 2.6.1 in disrupting quorum sensing and attenuating virulence in Listeria monocytogenes
    Isabela Sguilla Rotta, Sthefânia Dalva da Cunha Rezende, Hugo Felix Perini, Marcos Vinicius da Silva, Felipe Alves de Almeida, Uelinton Manoel Pinto, Alessandra Barbosa Ferreira Machado, Aline Dias Paiva
    Frontiers in Microbiology.2025;[Epub]     CrossRef
  • A review of structure-activity relationship, enzymatic and genetic modulation of exopolysaccharides from lactic acid bacteria
    Jingyan Zhang, Tao Hu, Qingshen Sun
    Food Science and Human Wellness.2025; 14(8): 9250368.     CrossRef
  • Essential Oil Emulsions from Xylopia Villosa and Hyparrhena Rufa as Potent Antimicrobial and Antibiofilm Agents
    Akua Gyamfi, Randolf Benle, Michael Konney Laryea, Mercy Badu, Lawrence Sheringham Borquaye
    Chemistry Africa.2025; 8(10): 5165.     CrossRef
  • Antimicrobial activity and safety profile of Lactiplantibacillus plantarum LY-21: Genomic and phenotypic insights
    Yang Du, Lijia Wang, Jingru Xu, Shitong Zhao, Jinquan Li, Renwei Wu
    Food Bioscience.2025; 74: 108026.     CrossRef
  • Investigating the effect of Lactiplantibacillus plantarum TW57-4 in preventing biofilm formation and expression of virulence genes in Listeria monocytogenes ATCC 19115
    Arezou Rouhi, Fereshteh Falah, Marjan Azghandi, Behrooz Alizadeh Behbahani, Seyed Ali Mortazavi, Farideh Tabatabaei-Yazdi, Alireza Vasiee
    LWT.2024; 191: 115669.     CrossRef
  • Exploring Technological, Safety and Probiotic Properties of Enterococcus Strains: Impact on Rheological Parameters in Fermented Milk
    Souraya Sakoui, Reda Derdak, Oana Lelia Pop, Dan Cristian Vodnar, Fatimazahra Jouga, Bernadette-Emőke Teleky, Boutaina Addoum, Elemér Simon, Ramona Suharoschi, Abdelaziz Soukri, Bouchra El Khalfi
    Foods.2024; 13(4): 586.     CrossRef
  • Determination of Antioxidant and Antimicrobial Activities of Cell-Free Supernatant (CFSKC27L) and Exopolysaccharide (EPSKC27L) obtained from Ligilactobacillus salivarius KC27L
    Kübra Çelik, Zehranur Yuksekdag, Berat Çınar Acar, Filiz Kara
    Tekirdağ Ziraat Fakültesi Dergisi.2024; 21(4): 928.     CrossRef
  • Limosilactobacillus fermentum MYSY8, a Potential Probiotic Isolate from Fermented Rice Beverage for the Control of Microsporum canis
    Padur Ramachandra Vanitha, Divyashree Shivakumar, Shruthi Basavaraj, Adithi Gunduraj, Dhanuja Janardanachar, Deepthi BV, Marikunte Yanjarappa Sreenivasa
    Food Biotechnology.2024; 38(3): 314.     CrossRef
  • Exploration of Antibiofilm Activities of Pediococci Strains Against Diarrheal Multi-Drug Resistant E.coli Strains
    Gunjan Sadera, Anjali Jaglan, Ashwani Kumar, Teresa Requena, Rakesh Kumar, Aparna Parmar, Gunjan Goel
    Food Biotechnology.2024; 38(4): 385.     CrossRef
  • Multivariate analysis of structural and functional properties of fibres from apple pomace using different extraction methods
    Rusli Fidriyanto, Brij Pal Singh, K. M. Manju, Yantyati Widyastuti, Gunjan Goel
    Food Production, Processing and Nutrition.2023;[Epub]     CrossRef
  • Antifungal activity of probiotic strain Lactiplantibacillus plantarum MYSN7 against Trichophyton tonsurans
    P. R. Vanitha, Rakesh Somashekaraiah, S. Divyashree, Indranil Pan, M. Y. Sreenivasa
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Synergistic combination of malic acid with sodium hypochlorite impairs biofilm of Cronobacter sakazakii
    Rajni Chauhan, Savita Kumari, Gunjan Goel, Wamik Azmi
    LWT.2022; 155: 112902.     CrossRef
  • Antibacterial and Antibiofilm Effect of Cell-Free Supernatant of Lactobacillus brevis KCCM 202399 Isolated from Korean Fermented Food against Streptococcus mutans KCTC 5458
    Jong Ha Kim, Hye Ji Jang, Na-Kyoung Lee, Hyun-Dong Paik
    Journal of Microbiology and Biotechnology.2022; 32(1): 56.     CrossRef
  • Selection of a Potential Synbiotic against Cronobacter sakazakii
    ALFRED KE, VALERIA R. PARREIRA, JEFFREY M. FARBER, LAWRENCE GOODRIDGE
    Journal of Food Protection.2022; 85(9): 1240.     CrossRef
  • Black cherry fruit as a source of probiotic candidates with antimicrobial and antibiofilm activities against Salmonella
    S. Divyashree, P.G Anjali, B.V. Deepthi, Rakesh Somashekaraiah, Walid Mottawea, Riadh Hammami, M.Y. Sreenivasa
    South African Journal of Botany.2022; 150: 861.     CrossRef
  • Anti-biofilm effect of the cell-free supernatant of probiotic Saccharomyces cerevisiae against Listeria monocytogenes
    Yeon Jin Kim, Hwan Hee Yu, Ye Ji Song, Yeong Jin Park, Na-Kyoung Lee, Hyun-Dong Paik
    Food Control.2021; 121: 107667.     CrossRef
  • Probiotic properties of Lactobacillus casei – MYSRD 108 and Lactobacillus plantarum-MYSRD 71 with potential antimicrobial activity against Salmonella paratyphi
    S. Divyashree, P.G. Anjali, Rakesh Somashekaraiah, M.Y. Sreenivasa
    Biotechnology Reports.2021; 32: e00672.     CrossRef
  • Intestinal microbiota and inflammatory bowel diseases
    Chang Soo Eun
    Journal of the Korean Medical Association.2021; 64(9): 588.     CrossRef
  • Current and Future Perspectives on the Role of Probiotics, Prebiotics, and Synbiotics in Controlling Pathogenic Cronobacter Spp. in Infants
    Alfred Ke, Valeria R. Parreira, Lawrence Goodridge, Jeffrey M. Farber
    Frontiers in Microbiology.2021;[Epub]     CrossRef
  • Impairment of Cronobacter sakazakii and Listeria monocytogenes biofilms by cell-free preparations of lactobacilli of goat milk origin
    Niharika Singh, Ravinder Kaur, Brij Pal Singh, Namita Rokana, Gunjan Goel, Anil Kumar Puniya, Harsh Panwar
    Folia Microbiologica.2020; 65(1): 185.     CrossRef
  • The Battle of Probiotics and Their Derivatives Against Biofilms


    Abolfazl Barzegari, Keyvan Kheyrolahzadeh, Seyed Mahdi Hosseiniyan Khatibi, Simin Sharifi, Mohammad Yousef Memar, Sepideh Zununi Vahed
    Infection and Drug Resistance.2020; Volume 13: 659.     CrossRef
  • Postbiotics against Pathogens Commonly Involved in Pediatric Infectious Diseases
    Anastasia Mantziari, Seppo Salminen, Hania Szajewska, Jeadran Nevardo Malagón-Rojas
    Microorganisms.2020; 8(10): 1510.     CrossRef
  • 12,468 View
  • 321 Download
  • 25 Web of Science
  • 24 Crossref
Close layer
Review
Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
Jung Mogg Kim
Intest Res 2014;12(1):20-33.   Published online January 28, 2014
DOI: https://doi.org/10.5217/ir.2014.12.1.20
AbstractAbstract PDFPubReader

Mucosal surface of the intestinal tract is continuously exposed to a large number of microorganisms. To manage the substantial microbial exposure, epithelial surfaces produce a diverse arsenal of antimicrobial proteins (AMPs) that directly kill or inhibit the growth of microorganisms. Thus, AMPs are important components of innate immunity in the gut mucosa. They are frequently expressed in response to colonic inflammation and infection. Expression of many AMPs, including human β-defensin 2-4 and cathelicidin, is induced in response to invasion of pathogens or enteric microbiota into the mucosal barrier. In contrast, some AMPs, including human α-defensin 5-6 and human β-defensin 1, are constitutively expressed without microbial contact or invasion. In addition, specific AMPs are reported to be associated with inflammatory bowel disease (IBD) due to altered expression of AMPs or development of autoantibodies against AMPs. The advanced knowledge for AMPs expression in IBD can lead to its potential use as biomarkers for disease activity. Although the administration of exogenous AMPs as therapeutic strategies against IBD is still at an early stage of development, augmented induction of endogenous AMPs may be another interesting future research direction for the protective and therapeutic purposes. This review discusses new advances in our understanding of how intestinal AMPs protect against pathogens and contribute to pathophysiology of IBD.

Citations

Citations to this article as recorded by  
  • The AMP–antibiotic–microbiota triad in IBD: a mechanistic framework for dysregulated antimicrobial defense
    Yuyuan Hu, Yan Li, Qiang Zhang, Qiaobo Tan, Haoze Liu, Yuhang Yang, Chenfei Jin, Wei Zhang, Jinghan Jia, Jinxi Wang
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Carrier-free supramolecular architectonics of quercetin–berberine for safety-redefined therapy of ulcerative colitis
    Xinyu Zhang, Yan Fu, Shuohong Liu, Jiayi Zhang, Fei Xu, Chao Zhang, Yufang Wang, Changhong Huo
    Materials Today Bio.2026; 37: 102970.     CrossRef
  • Melatonin-induced restoration of the intestinal mucosal barrier in inflammatory bowel disease via activation of the SIRT1-LKB1-pAMPK axis
    Qingyi Mao, Beibei Lin, Wenhao Xia, Yu Zhang, Yue Lei, Qian Cao, Mengque Xu
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability
    Bentley Lim, Jinghua Xu, Igor H. Wierzbicki, Carlos G. Gonzalez, Zhe Chen, David J. Gonzalez, Xiang Gao, Andrew L. Goodman
    Cell Host & Microbe.2025; 33(2): 200.     CrossRef
  • MyD88-mediated signaling in intestinal fibroblasts regulates macrophage antimicrobial defense and prevents dysbiosis in the gut
    Marina Chulkina, Hanh Tran, Gabriela Uribe, Steven Bruce McAninch, Christina McAninch, Ashley Seideneck, Bing He, Matthew Lanza, Kamil Khanipov, Georgiy Golovko, Don W. Powell, Emily R. Davenport, Irina V. Pinchuk
    Cell Reports.2025; 44(5): 115553.     CrossRef
  • Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota
    Shari Garrett, Yongguo Zhang, Yinglin Xia, Jun Sun
    Engineering.2024; 35: 241.     CrossRef
  • Evaluation of potential antiviral activities of antimicrobial peptides in fish mucus
    Irmak Dik, Burak Dik, Öznur Tufan, Ayşe Er
    Fundamental & Clinical Pharmacology.2024; 38(4): 695.     CrossRef
  • Role of antimicrobial peptides in gastrointestinal diseases: Recent advances
    Xia Xu, Yan-Bo Yu
    World Chinese Journal of Digestology.2024; 32(12): 865.     CrossRef
  • Importance of Fecal Microbiota Transplantation and Molecular Regulation as Therapeutic Strategies in Inflammatory Bowel Diseases
    Olga Brusnic, Adrian Boicean, Sorin-Radu Fleacă, Blanca Grama, Florin Sofonea, Corina Roman-Filip, Iulian Roman-Filip, Adelaida Solomon, Sabrina Bîrsan, Horatiu Dura, Corina Porr, Cristian Adrian, Danusia Onisor
    Nutrients.2024; 16(24): 4411.     CrossRef
  • A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
    Deeksha, Shalini Saini, Meenakshi Bhatt
    International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
  • Oral Delivery of Mouse β-Defensin 14 (mBD14)-Producing Lactococcus lactis NZ9000 Attenuates Experimental Colitis in Mice
    Haizhi Tian, Jiahong Li, Xiaopei Chen, Zhengnan Ren, Xiaohua Pan, Weining Huang, Madhav Bhatia, Li-Long Pan, Jia Sun
    Journal of Agricultural and Food Chemistry.2023; 71(13): 5185.     CrossRef
  • Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota
    Zarwa Saqib, Giada De Palma, Jun Lu, Michael Surette, Premysl Bercik, Stephen Michael Collins
    Gut Microbes.2023;[Epub]     CrossRef
  • COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy
    Yogesh Kumar Verma, Ranjan Verma, Nishant Tyagi, Amanpreet Behl, Subodh Kumar, Gurudutta U. Gangenahalli
    Stem Cell Reviews and Reports.2021; 17(1): 113.     CrossRef
  • Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease
    Paulina Krawiec, Elżbieta Pac-Kożuchowska
    Journal of Inflammation Research.2021; Volume 14: 163.     CrossRef
  • Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model
    Harpreet Kaur, Taruna Gupta, Suman Kapila, Rajeev Kapila
    Food & Function.2021; 12(13): 6102.     CrossRef
  • Human β-Defensin 2 and Its Postulated Role in Modulation of the Immune Response
    Martyna Cieślik, Natalia Bagińska, Andrzej Górski, Ewa Jończyk-Matysiak
    Cells.2021; 10(11): 2991.     CrossRef
  • Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases
    Johanna Born, Alexander Hendricks, Charlotte Hauser, Jan-Hendrik Egberts, Thomas Becker, Christian Röder, Susanne Sebens
    Cancers.2021; 14(1): 47.     CrossRef
  • Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation
    Silin Chen, Xiaopeng Li, Ming Li, Qing Mei, Juanjun Huang, Zhenping Wu, Lunli Zhang
    Gastroenterología y Hepatología.2020; 43(6): 293.     CrossRef
  • High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures
    Jiani Wang, Christina Ortiz, Lindsey Fontenot, Ying Xie, Wendy Ho, S. Anjani Mattai, David Q. Shih, Hon Wai Koon, Pal Bela Szecsi
    PLOS ONE.2020; 15(4): e0231796.     CrossRef
  • Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics
    Nehal Adel Abdelsalam, Ahmed Tarek Ramadan, Marwa Tarek ElRakaiby, Ramy Karam Aziz
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation
    Silin Chen, Xiaopeng Li, Ming Li, Qing Mei, Juanjun Huang, Zhenping Wu, Lunli Zhang
    Gastroenterología y Hepatología (English Edition).2020; 43(6): 293.     CrossRef
  • Mesenchymal Stromal Cells as Potential Antimicrobial for Veterinary Use—A Comprehensive Review
    Keith A. Russell, Livia C. Garbin, Jonathan M. Wong, Thomas G. Koch
    Frontiers in Microbiology.2020;[Epub]     CrossRef
  • Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
    Seong-Joon Koh, Youn-I Choi, Yuri Kim, Yoo-Sun Kim, Sang Woon Choi, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee
    European Journal of Nutrition.2019; 58(4): 1603.     CrossRef
  • Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
    Ajaz A. Bhat, Srijayaprakash Uppada, Iman W. Achkar, Sheema Hashem, Santosh K. Yadav, Muralitharan Shanmugakonar, Hamda A. Al-Naemi, Mohammad Haris, Shahab Uddin
    Frontiers in Physiology.2019;[Epub]     CrossRef
  • Gene and Mirna Regulatory Networks During Different Stages of Crohn’s Disease
    Sare Verstockt, Gert De Hertogh, Jan Van der Goten, Bram Verstockt, Maaike Vancamelbeke, Kathleen Machiels, Leentje Van Lommel, Frans Schuit, Gert Van Assche, Paul Rutgeerts, Marc Ferrante, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
    Journal of Crohn's and Colitis.2019; 13(7): 916.     CrossRef
  • Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction
    Gabriela Pinget, Jian Tan, Bartlomiej Janac, Nadeem O. Kaakoush, Alexandra Sophie Angelatos, John O'Sullivan, Yen Chin Koay, Frederic Sierro, Joel Davis, Shiva Kamini Divakarla, Dipesh Khanal, Robert J. Moore, Dragana Stanley, Wojciech Chrzanowski, Lauren
    Frontiers in Nutrition.2019;[Epub]     CrossRef
  • Duodenal expression of antimicrobial peptides in dogs with idiopathic inflammatory bowel disease and intestinal lymphoma
    M. Nakazawa, S. Maeda, M. Omori, K. Kaji, N. Yokoyama, T. Nakagawa, J.K. Chambers, K. Uchida, K. Ohno, T. Yonezawa, N. Matsuki
    The Veterinary Journal.2019; 249: 47.     CrossRef
  • Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies
    Liang Jin, Li Li, Chenqi Hu, Jesus Paez-Cortez, Yingtao Bi, Michael Macoritto, Sherry Cao, Yu Tian
    Inflammatory Bowel Diseases.2019; 25(12): 1906.     CrossRef
  • Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells
    Reza Esfandiyari, Raheleh Halabian, Elham Behzadi, Hamid Sedighian, Ramezan Jafari, Abbas Ali Imani Fooladi
    Heliyon.2019; 5(10): e02652.     CrossRef
  • Intestinal barrier integrity and inflammatory bowel disease: Stem cell‐based approaches to regenerate the barrier
    Fredrik E.O. Holmberg, Jannie Pedersen, Peter Jørgensen, Christoffer Soendergaard, Kim B. Jensen, Ole H. Nielsen
    Journal of Tissue Engineering and Regenerative Medicine.2018; 12(4): 923.     CrossRef
  • Growth characteristics of Chlamydia trachomatis in human intestinal epithelial Caco-2 cells
    Ildikó Lantos, Dezső P Virok, Tímea Mosolygó, Zsolt Rázga, Katalin Burián, Valéria Endrész
    Pathogens and Disease.2018;[Epub]     CrossRef
  • The DH31/CGRP enteroendocrine peptide triggers intestinal contractions favoring the elimination of opportunistic bacteria
    Olivia Benguettat, Rouba Jneid, Julie Soltys, Rihab Loudhaief, Alexandra Brun-Barale, Dani Osman, Armel Gallet, Karel Talavera
    PLOS Pathogens.2018; 14(9): e1007279.     CrossRef
  • P17, an Original Host Defense Peptide from Ant Venom, Promotes Antifungal Activities of Macrophages through the Induction of C-Type Lectin Receptors Dependent on LTB4-Mediated PPARγ Activation
    Khaddouj Benmoussa, Hélène Authier, Mélissa Prat, Mohammad AlaEddine, Lise Lefèvre, Mouna Chirine Rahabi, José Bernad, Agnès Aubouy, Elsa Bonnafé, Jérome Leprince, Bernard Pipy, Michel Treilhou, Agnès Coste
    Frontiers in Immunology.2017;[Epub]     CrossRef
  • Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA
    Maureen C. Turina, Robert Landewé, Dominique Baeten
    Expert Review of Clinical Immunology.2017; 13(4): 333.     CrossRef
  • Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia
    Junbae Jee, Reena Mourya, Pranavkumar Shivakumar, Lin Fei, Michael Wagner, Jorge A. Bezerra, Gianfranco D. Alpini
    PLOS ONE.2017; 12(8): e0182089.     CrossRef
  • Metronidazole-induced encephalopathy in a patient with Crohn's disease
    Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
    Intestinal Research.2017; 15(1): 124.     CrossRef
  • Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review
    Alexander L.A. Bloemendaal, Nicolas C. Buchs, Bruce D. George, Richard J. Guy
    Surgery.2016; 159(5): 1237.     CrossRef
  • Antimicrobial peptides and wound healing: biological and therapeutic considerations
    Maria Luisa Mangoni, Alison M. McDermott, Michael Zasloff
    Experimental Dermatology.2016; 25(3): 167.     CrossRef
  • The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease
    Lihua Sun, Wensheng Wang, Weidong Xiao, Hua Yang
    Inflammatory Bowel Diseases.2016; 22(8): 1986.     CrossRef
  • A glance at … dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber
    Michael J. Glade, Michael M. Meguid
    Nutrition.2016; 32(5): 609.     CrossRef
  • Antimicrobial and antiviral effects of human defensins: pathogenetic value and prospective application to medicinal therapy
    Vladimir I Vaschenko, Vladimir N Vil’yaninov, Petr D Shabanov
    Reviews on Clinical Pharmacology and Drug Therapy.2016; 14(2): 3.     CrossRef
  • Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease
    Da Yeon Oh, Seong-Joon Koh
    Gut and Liver.2015;[Epub]     CrossRef
  • Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
    Joo Mi Yi, Tae Oh Kim
    Intestinal Research.2015; 13(2): 112.     CrossRef
  • 16,040 View
  • 183 Download
  • 41 Web of Science
  • 43 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP